Ultrasound-guided ilioinguinal-iliohypogastric block or perifocal wound infiltration in children: a prospective randomized comparison of analgesia quality, a pilot study

Organizational Data

DRKS-ID:
DRKS00020987
Recruitment Status:
Recruiting complete, study complete
Date of registration in DRKS:
2020-03-20
Last update in DRKS:
2020-11-05
Registration type:
Retrospective

Acronym/abbreviation of the study

UIHBOPWIIC

URL of the study

No Entry

Brief summary in lay language

The Ilioinguinal-iliohypogastric block (ILIHB) and perifocal wound infiltrtaion (PWI) are both established regional anaesthesia procedures for inguinal surgery in children. Data availability for comparing ultrasound-guided blocks versus wound infiltration, by means of ultrasound-guided procedures, is still absent. Ultrasound guided ILIHB ensures better postoperative analgesia in children and should be prioritized over postoperative PWI.

Brief summary in scientific language

Background: Ilioinguinal-iliohypogastric block (ILIHB) is a well-established procedure for postoperative analgesia after open inguinal surgery in children. This procedure is effective and safe, especially when ultrasound is used. Data availability for comparing ultrasound-guided blocks versus wound infiltration is still weak. The study was designed to determine the efficacy of ultrasound-guided ILIHB (US-ILIHB) on postoperative pain control in pediatric patients following a inguinal daycase surgery, compared with perifocal wound infiltration (PWI) by the surgeon. Methods: This randomized, double-blinded trail was conducted in pediatric patients aged from 6 months to 4 years. The total number of children included in the study was 103. Patients were allocated in two groups. The ILIHB group recieved 0,2% ropivacain for US-ILIHB after anesthesia induction. The PWI group recieved 0,2% ropivavain for PWI performed by a surgeon before wound closure. Parameters recorded included the postoperative pain score, pain frequency, time to first analgesics and consumption of analgesics. Results: US-ILIHB significantly reduced the occurrence of pain within the first 24 hours after surgery (7.7%, p = 0.01). Moreover, the pain-free interval until administration of the first dose of opioids was 21 minutes longer, on average (p = 0.003), following US-ILIHB compared to perifocal wound infiltration. 72% of children who received US-ILIHB did not require additional opioids, as compared to 56% of those who received PWI. Conclusion: Thus our study demonstrates that US-ILIHB ensures better postoperative analgesia in children and should be prioritized over postoperative PWI.

Health condition or problem studied

Free text:
Efficacy of ultrasound-controlled ILIHB (US-ILIHB) via postoperative pain control in pediatric patients after outpatient groin surgery
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
Ilioinbuinal-Iliohypogastric Block
Arm 2:
Perficoal Wound Infiltration

Endpoints

Primary outcome:
Measurement of the postoperative pain score in the recovery room using a pain assessment questionnaire
Secondary outcome:
Calculate the total painkiller requirement as well as the time until the first painkiller administration

Study Design

Purpose:
Treatment
Allocation:
Randomized controlled study
Control:
  • Active control (effective treatment of control group)
Phase:
III
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
Yes
Assignment:
Crossover
Sequence generation:
No Entry
Who is blinded:
  • Assessor
  • Patient/subject

Recruitment

Recruitment Status:
Recruiting complete, study complete
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • Medical center Kinderkrankenhaus Altona Hamburg

Recruitment period and number of participants

Planned study start date:
No Entry
Actual study start date:
2017-02-09
Planned study completion date:
No Entry
Actual Study Completion Date:
2018-05-01
Target Sample Size:
120
Final Sample Size:
103

Inclusion Criteria

Sex:
All
Minimum Age:
6 Months
Maximum Age:
4 Years
Additional Inclusion Criteria:
6 months - 4 years, ASAI-II, unilateral daycase inguinal surgery

Exclusion Criteria

Diseases, Allergies, Emergencies, multiple interventions

Addresses

Primary Sponsor

Address:
Kinderkrankenhaus Altona Kinderchirurgie
Prof. Konrad Reinshagen
Bleickenallee 38
22763 Hamburg
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Altonaer Kinderkrankenhaus Hamburg /UKE Hamburg Kinderchirurgie
Prof. Konrad Reinshagen
Bleickenalle 38
22763 Hamburg
Germany
Telephone:
04088908230
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.kinderkrankenhaus.net/unsere-medizinischen-bereiche-im-ueberblick/fachabteilungen/kinderchirurgie-im-altonaer-kinderkrankenhaus.html

Contact for Public Queries

Address:
Altonaer Kinderkrankenhaus Hamburgdes/ UKE Hamburg Kinderchirurgie
Prof. Konrad Reinshagen
Bleickenallee 38
22763 Hamburg
Germany
Telephone:
04088908230
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.kinderkrankenhaus.net/unsere-medizinischen-bereiche-im-ueberblick/fachabteilungen/kinderchirurgie-im-altonaer-kinderkrankenhaus.html

Principal Investigator

Address:
Altonaer Kinderkrankenhaus Hamburg /UKE Hamburg Kinderchirurgie
Prof. Konrad Reinshagen
Bleickenalle 38
22763 Hamburg
Germany
Telephone:
04088908230
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.kinderkrankenhaus.net/unsere-medizinischen-bereiche-im-ueberblick/fachabteilungen/kinderchirurgie-im-altonaer-kinderkrankenhaus.html

Sources of Monetary or Material Support

Private sponsorship (foundations, study societies, etc.)

Address:
Kinderkrankenhaus Altona
22763 Hamburg
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Altonaer Kinderkrankenhaus Hamburg Kinderchirurgie
Bleickenallee 38
22763 Hamburg
Germany
Telephone:
04088908230
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Ethics Committee

Address Ethics Committee

Address:
Ethik-Kommission der Ärztekammer Hamburg
Weidestraße 122 b
22083 Hamburg
Germany
Telephone:
+49-40-2022990
Fax:
+40-40-202299410
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2016-03-17
Ethics committee number:
PV5270
Vote of the Ethics Committee:
Approved
Date of the vote:
2016-05-17

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
Yes
IPD Sharing Plan:
study protocol

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
Grosse et al. BMC Anesthesiology (2020) 20:256
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry